Andreas Lieb

10PUBLICATIONS

42CO-AUTHORS

Electrical energy generation (incl. renewables, excl. photovoltaics)Proteins and peptidesMolecular targetsNeurology and neuromuscular diseasesVirtual and mixed reality

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jun 18, 2026

Activity-dependent antioxidant gene therapy protects against epileptogenesis.

|Jan 25, 2025

Disease-Associated Dopamine Receptor D2 Variants Exhibit Functional Consequences Depending on Different Heterotrimeric G-Protein Subunit Combinations.

Nele Niebrügge, Olga Trovato, Roman Praschberger

|Jul 13, 2023

Disruptor: Computational identification of oncogenic mutants disrupting protein-protein and protein-DNA interactions.

Valentina Kugler, Andreas Lieb, Nathan Guerin

|Dec 24, 2021

Functional Characterization of Spinocerebellar Ataxia Associated Dynorphin A Mutant Peptides.

Andreas Lieb, Germana Thaler, Barbara Fogli

|Jul 14, 2019

AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders.

Vincenzo Salpietro, Christine L Dixon, Hui Guo

|Apr 20, 2019

Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics.

Mikail Weston, Teresa Kaserer, Angela Wu

Pageof 2

Frequent Collaborators

Dimitri M Kullmann

Teresa Kaserer

Albert Snowball

Tawfeeq Shekh-Ahmad

Stephanie Schorge

Janosch P Heller

Petronel Tuluc

Gabriele Lignani

Elodie Chabrol

Jonathan H Cornford

Frequent Collaborators

Dimitri M Kullmann

Teresa Kaserer

Albert Snowball

Tawfeeq Shekh-Ahmad